The global market for Stem Cell Engineering in biomaterials is experiencing robust growth driven by advancements in regenerative medicine and the need for novel therapies for chronic diseases. According to a report by Fortune Business Insights, the stem cells market, a related sector, is projected to reach $50.4 billion by 2027, at a CAGR of 6.6% from 2020. Stem cell engineering's role in creating therapies for conditions like cancer, neurodegenerative disorders, and cardiac diseases is propelling this market. Although ethical considerations and regulatory hurdles pose challenges, the potential for breakthroughs in personalized medicine and tissue engineering presents significant opportunities.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by